News|Articles|October 25, 2022
AAPS 2022 Conference Highlights
Author(s)Alivia Leon
Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Com, discuss cell & gene therapies and co-processed APIs respectively.
Advertisement
At the AAPS 2022 conference in Boston, Pharmaceutical Technology interviewed Vibha Jawa, executive director at Bristol Myers Squibb, and Luke Schenck, principal scientist at Merck & Co. We spoke with Vibha Jawa about her expertise in the field of cell & gene therapies, specifically CAR-T cells. Luke Schenck discussed his knowledge on co-processed APIs. To see the highlights of our interviews with these experts, click the video below.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Pharma's AI ROI Problem Isn't a Tech Problem but a Qualification Problem
2
Danish Biotechs Attracting Investor Attention
3
BMS Bets on Flexible Capacity With $2.3B Texas Campus
4
Three Formats, One Platform: Halo's New Sterile Fill-Finish Line
5